FDA Approved: NELARABINE — Original Application (Shorla Oncology Inc.)

View source ↗

Summary

The FDA approved a generic Nelarabine (Shorla Oncology Inc.) under an Original Abbreviated New Drug Application, confirming bioequivalence to the reference prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• Nelarabine (Nelarabine)

Snippet

ORIG AP for NELARABINE (NELARABINE)